1 |
Carreto-Binaghi LE,Aliouat el M,Taylor ML.Surfactant proteins,SP-A and SP-D,in respiratory fungal infections: their role in the inflammatory response[J].Respir Res,2016,17 (1): 66.
|
2 |
Zhang L,Meng Q,Yepuri N,et al.Surfactant proteins-A and -D attenuate LPS-induced apoptosis in primary intestinal epithelial cells (IECs)[J].Shock,2018,49 (1): 90-98.
|
3 |
Brauer L,Moschter S,Beileke S,et al.Human parotid and submandibular glands express and secrete surfactant proteins A,B,C and D [J].Histochem Cell Biol,2009,132 (3): 331-338.
|
4 |
Schicht M,Stengl C,Sel S,et al.The distribution of human surfactant proteins within the oral cavity and their role during infectious diseases of the gingiva[J].Ann Anat,2015 (199): 92-97.
|
5 |
Workman AD,Kohanski MA,Cohen NA.Biomarkers in chronic rhinosinusitis with nasal polyps[J].Immunol Allergy Clin North Am,2018,38 (4): 679-692.
|
6 |
Imtiazul IM,Asma R,Lee JH,et al.Change of surfactant protein D and A after renal ischemia reperfusion injury[J].PLoS One,2019,14 (12): e227097.
|
7 |
Avci S,Kuscu N,Kilinc L,et al.Relationship of Notch signal,surfactant protein A,and indomethacin in cervix during preterm birth: mast cell and jagged-2 may be key in understanding infection-mediated preterm birth[J].J Histochem Cytochem,2022,70 (2):121-138.
|
8 |
Nayak A,Dodagatta-Marri E,Tsolaki AG,et al.An insight into the diverse roles of surfactant proteins,SPA and SP-D in innate and adaptive immunity [J].Front Immunol,2012 (3): 131.
|
9 |
Du X,Meng Q,Sharif A,et al.Surfactant proteins SP-A and SP-D ameliorate pneumonia severity and intestinal injury in a murine model of Staphylococcus aureus pneumonia[J].Shock,2016,46 (2): 164-172.
|
10 |
Floros J,Thorenoor N,Tsotakos N,et al.Human surfactant protein SP-A1 and SP-A2 variants differentially affect the alveolar microenvironment,surfactant structure,regulation and function of the alveolar macrophage,and animal and human survival under various conditions[J].Front Immunol,2021 (12):681639.
|
11 |
Watson A,Madsen J,Clark HW.SP-A and SP-D:dual functioning immune molecules with antiviral and immunomodulatory properties [J].Front Immunol,2020(11): 622598.
|
12 |
Kim K,Shin D,Lee G,et al.Loss of SP-A in the lung exacerbates pulmonary fibrosis [J].Int J Mol Sci,2022,23 (10): 5292.
|
13 |
King SD,Chen SY.Recent progress on surfactant protein A: cellular function in lung and kidney disease development[J].Am J Physiol Cell Physiol,2020,319(2): C316-C320.
|
14 |
Madan T.Potential of lung surfactant proteins,SP-A and SP-D,and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis [J].Recent Pat Inflamm Allergy Drug Discov,2007,1 (3): 183-187.
|
15 |
Jahanmehr N,Izadi R,Habibolahi A,et al.Irrational prescription of surfactant replacement therapy in neonatal respiratory distress [J].PLoS One,2022,17(6): e268774.
|
16 |
Vieira F,Kung JW,Bhatti F.Structure,genetics and function of the pulmonary associated surfactant proteins A and D: the extra-pulmonary role of these C type lectins[J].Ann Anat,2017 (211): 184-201.
|
17 |
Ledford JG,Addison KJ,Foster MW,et al.Eosinophil-associated lung diseases.A cry for surfactant proteins A and D help?[J].Am J Respir Cell Mol Biol,2014,51 (5): 604-614.
|
18 |
Zhang X,Wang Y,He X,et al.Diagnosis of chronic obstructivepulmonarydiseaseandregulatory mechanism of miR-149-3p on alveolar inflammatory factors and expression of surfactant proteins A (SP-A)and D (SP-D) on lung surface mediated by Wnt pathway [J].Comput Intell Neurosci,2022 (2022):7205016.
|
19 |
Chailley-Heu B,Rubio S,Rougier JP,et al.Expression of hydrophilic surfactant proteins by mesentery cells in rat and man [J].Biochem J,1997,328 (Pt 1): 251-256.
|
20 |
Minutti CM,García-Fojeda B,Sáenz A,et al.Surfactant protein A prevents IFN-γ / IFN-γ receptor interaction and attenuates classical activation of human alveolar macrophages [J].J Immunol,2016,197 (2):590-598.
|
21 |
Schicke E,Cseresnyés Z,Rennert K,et al.Staphylococcus aureus lung infection results in downregulation of surfactant protein-A mainly caused by pro-inflammatory macrophages [J].Microorganisms,2020,8 (4): 577.
|
22 |
Nathan N,Taytard J,Duquesnoy P,et al.Surfactant protein A: a key player in lung homeostasis [J].Int J Biochem Cell Biol,2016,81 (Pt A): 151-155.
|
23 |
Madhukaran SP,Kishore U,Jamil K,et al.Decidual expression and localization of human surfactant protein SP-A and SP-D,and complement protein C1q[J].Mol Immunol,2015,66 (2): 197-207.
|
24 |
Tsuruta T,Inoue R,Nagino T,et al.Role of the mannose receptor in phagocytosis of Enterococcus faecalis strain EC-12 by antigen-presenting cells [J].Microbiologyopen,2013,2 (4): 610-617.
|
25 |
Veith NT,Tschernig T,Gutbier B,et al.Surfactant proteinAmediatespulmonaryclearanceof Staphylococcus aureus[J].Respir Res,2014,15 (1): 85.
|
26 |
Xue M,Xu S,Su L,et al.Surfactant protein-A inhibits thymic stromal lymphopoietin-mediated T follicular helper cell differentiation and IgE production in asthma[J].Clin Immunol,2021 (231): 108822.
|
27 |
Sender V,Lang L,Stamme C.Surfactant protein-A modulates LPS-induced TLR4 localization and signaling via β-arrestin 2[J].PLoS One,2013,8 (3): e59896.
|
28 |
Yang Y,Li Q,Tan F,et al.Mechanism of IL-8-induced acute lung injury through pulmonary surfactant proteins A and B [J].Exp Ther Med,2020,19 (1):287-293.
|
29 |
Lv MY,Qiang LX,Wang BC,et al.Complex evaluation of surfactant protein A and D as biomarkers for the severity of COPD [J].Int J Chron Obstruct Pulmon Dis,2022 (17): 1537-1552.
|
30 |
Bourbon JR,Chailley-Heu B.Surfactant proteins in the digestive tract,mesentery,and other organs:evolutionary significance [J].Comp Biochem Physiol A Mol Integr Physiol,2001,129 (1): 151-161.
|
31 |
Luo JM,Liu ZQ,Eugene CY.Overexpression of pulmonary surfactant protein A like molecules in inflammatory bowel disease tissues [J].Zhong Nan Da Xue Xue Bao Yi Xue Ban,2008,33 (11): 979-986.
|
32 |
Gowdy KM,Cardona DM,Nugent JL,et al.Novel role for surfactant protein A in gastrointestinal graftversus-host disease [J].J Immunol,2012,188 (10):4897-4905.
|
33 |
Quintanilla HD,Liu Y,Fatheree NY,et al.Oral administration of surfactant protein-A reduces pathology in an experimental model of necrotizing enterocolitis[J].J Pediatr Gastroenterol Nutr,2015,60 (5): 613-620.
|
34 |
Kariyawasam JC,Jayarajah U,Riza R,et al.Gastrointestinal manifestations in COVID-19 [J].Trans R Soc Trop Med Hyg,2021,115 (12): 1362-1388.
|
35 |
Dominguez JA,Vithayathil PJ,Khailova L,et al.Epidermal growth factor improves survival and prevents intestinal injury in a murine model of Pseudomonas aeruginosa pneumonia [J].Shock,2011,36 (4): 381-389.
|
36 |
Mittal R,Coopersmith CM.Redefining the gut as the motor of critical illness[J].Trends Mol Med,2014,20(4): 214-223.
|
37 |
孟建标,张庚,焦燕娜.脓毒症合并心功能障碍患者早期肠道微生态改变的探讨[J/OL].中华危重症医学杂志(电子版),2023,16(4):279-285.
|
38 |
王田田,孙小平,张瑾,等.表面活性蛋白-A 二胺氧化酶与重症肺炎患者急性肠损伤的相关性分析及病情评估价值[J].中国急救医学,2023,43(1):30-36.
|
39 |
李冠胜,孙小平,张瑾,等.重症肺炎大鼠血清肺和肠组织中表面活性蛋白-A 的变化规律[J].中国急救医学,2022,42(9):791-797.
|
40 |
Enaud R,Prevel R,Ciarlo E,et al.The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks [J].Front Cell Infect Microbiol,2020 (10): 9.
|
41 |
Piersigilli F,Van Grambezen B,Hocq C,et al.Nutrients and microbiota in lung diseases of prematurity: the placenta-gut-lung triangle[J].Nutrients,2020,12 (2): 469.
|
42 |
郑继生,李志军,沈延飞,等.SP-A 在急性肠损伤大鼠大肠和肺组织中表达的相关性研究[J].中华中医药学刊,2013,31(8):1741-1744.
|
43 |
Yang J,Radulescu A,Chen CL,et al.Heparinbinding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis [J].Surgery,2013,153 (1): 52-62.
|
44 |
Hamai K,Iwamoto H,Ishikawa N,et al.Comparative study of circulating MMP-7,CCL18,KL-6,SP-A,and SP-D as disease markers of idiopathic pulmonary fibrosis[J].Dis Markers,2016 (2016): 4759040.
|
45 |
Wang J,Zheng P,Huang Z,et al.Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features [J].BMC Pulm Med,2020,20(1): 315.
|
46 |
Delgado C,Krotzsch E,Jiménez-Alvarez LA,et al.Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A / H1N1 virus infection[J].Lung,2015,193 (1): 25-30.
|
47 |
Ghati A,Dam P,Tasdemir D,et al.Exogenous pulmonary surfactant: a review focused on adjunctive therapy for severe acute respiratory syndrome coronavirus 2 including SP-A and SP-D as added clinical marker [J].Curr Opin Colloid Interface Sci,2021 (51): 101413.
|
48 |
Hentschel R,Bohlin K,van Kaam A,et al.Surfactant replacement therapy: from biological basis to current clinical practice[J].Pediatr Res,2020,88 (2):176-183.
|
49 |
Choi Y,Jang J,Park HS.Pulmonary surfactants: a new therapeutic target in asthma [J].Curr Allergy Asthma Rep,2020,20 (11): 70.
|